Length and width, not thickness, emerge as key drivers of higher-order aberrations.
Commentary|Videos|April 15, 2025
Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
Author(s)Francis S. Mah, MD, Sheryl Stevenson
Mah previews a packed 2025 Annual Meeting, from the debut of SightLine to Dr. Glaucomflecken’s return to the main stage, and outlines his priorities for the year ahead as incoming ASCRS president.
Advertisement
Advertisement
Francis S. Mah, MD, incoming president of the American Society of Cataract and Refractive Surgery (ASCRS), sat down with the Eye Care Network to share his goals and perspectives ahead of the 2025 ASCRS Annual Meeting, taking place April 25–28 in Los Angeles, California. The role is a 1-year term, and Mah sees it as an opportunity to build on the momentum of past leadership.
Related to this article
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
A retrospective study finds that direct selective laser trabeculoplasty significantly lowers intraocular pressure, with the greatest benefit seen in treatment-naive eyes.
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
The RMAT designation opens the door to a faster development pathway for EO2002 as a minimally invasive alternative to corneal transplantation, while Emmecell also advances a cell therapy for geographic atrophy.
Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
A large real-world cohort study finds OSA is associated with elevated glaucoma risk, though whether positive airway pressure therapy itself plays a role remains unclear.
Advertisement
Advertisement